Developer docs
API playgroundTry for free, no card

Search company profiles

Fingerpaint

Full company profile

uuid0007wrv

Namestring
Fingerpaint
Legal namestring
Fingerpaint Marketing, Inc.
Websiteurl
fingerpaint.com
Company typeenum
Private
Founded yearint
2008
Descriptiontext

Fingerpaint Group is a privately held, PE-backed (Knox Lane) integrated commercialization platform for life sciences, founded in 2008 and headquartered in Cedar Knolls, NJ with offices in Saratoga Springs, NY and London. The company serves global pharmaceutical, biotechnology, medical device, and animal health companies through eight specialized sub-brands: Marketing, Medical Communications, Medical Affairs, Market Access, Branding, Media & Activation, Multicultural, and Europe. Underlying these services is an AI-enabled technology stack including the proprietary Prima™ branding toolkit, LLM-powered unification of siloed life sciences data, predictive EPI-based patient modeling, and agentic frameworks integrated into operational workflows, governed by a newly appointed Chief Technology & Product Officer.

The company generates revenue through B2B professional services engagements, including project-based work, retainers, and integrated multi-solution contracts sold via direct enterprise sales to senior pharma decision-makers. Nearly 200 active clients span the top 20 global pharmaceutical companies (95% partnership rate) and 22 of the top 25, with over 60% of revenue from the top 50 pharma accounts and roughly half concentrated in oncology, immunology, and neurology. Two-thirds of partners engage multiple solutions across the platform, driving cross-sell economics and stickiness.

Growth has been propelled by an aggressive acquisition cadence (eight acquisitions since 2021 including Engage, Leaderboard, Emcay, Parsons Medical, PharmaHEALTHLabs, MYND, Blackpoint, and L&M Healthcare Communications), a 2025 record-revenue year with 21% growth, and a 2026 leadership transition that elevated internal successors to the CEO, Group President, and President of Marketing Services roles. The company has earned MM+M top-100 recognition for 15 consecutive years and became the first independent agency to win Network of the Year at the 2026 Manny Awards, validating the integrated platform thesis.

Short descriptiontext

Fingerpaint Group is a PE-backed, integrated life sciences commercialization platform serving 95% of the top 20 global pharma companies through eight AI-enabled sub-brands spanning marketing, medical communications, market access, and branding.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersSaratoga Springs, United States
HQ citystring
Saratoga Springs
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare marketing services, pharmaceutical commercialization, medical communications agency, market access solutions, pharmaceutical branding
Industry1 code
1Hand Hygiene & Skin Antisepsis (Soaps, Sanitizers, Surgical Scrubs, CHG Prep)
CodeHLAHANAEPrimaryYes
Product category
Healthcare Marketing and Commercialization Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Healthcare Marketing and Communications Services
TypeProfessional Services
Description

Full-service healthcare agency providing integrated commercialization services for life sciences companies. Revenue generated through project-based engagements, retainer agreements, and comprehensive marketing solutions spanning creative, strategy, media, and medical communications.

fingerpaint.com
2Integrated Platform Solutions
TypeProfessional Services
Description

Multi-solution platform generating cross-sell revenue. Two-thirds of partners engage multiple solutions across Marketing, Medical, Branding, and Market Access segments. Revenue mix includes high-growth therapeutic areas (oncology, immunology, neurology) representing half of all revenue.

Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 10 records shown
1Fingerpaint Marketing
Description

Core marketing services including creative, digital activation, strategy, media strategy, data analytics, and science solutions

fingerpaint.com
+9 more records
Core offering1 text field

Fingerpaint Group is an integrated healthcare commercialization agency that delivers marketing, medical communications, medical affairs, market access, branding, multicultural, media and activation, and European services to life sciences companies. It sells these to pharmaceutical, biotechnology, medical device, and animal health clients through eight specialized solution lines plus the proprietary Prima AI-powered branding toolkit, funded by project-based engagements and retainer agreements.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • 21% revenue growth in 2025 with record revenue
+3 more records
Product overview1 text field

Fingerpaint Group is a unified commercialization platform for life sciences, combining imagination with innovation to unlock brand greatness. The platform integrates multiple specialized solutions: Fingerpaint Marketing (core marketing and creative), Fingerpaint Multicultural (pharmacultural marketing), Fingerpaint Media and Activation (omnichannel media strategy), Fingerpaint Branding (pharmaceutical naming with proprietary Prima AI toolkit), Fingerpaint Market Access (patient support and 340B management), Fingerpaint Medical Communications (peer-to-peer education and speaker bureaus), and Fingerpaint Medical Affairs (publications and KOL engagement). Fingerpaint Europe extends capabilities across the continent. Supporting services include Mynd affiliate. The company has completed strategic acquisitions of Blackpoint (Market Access), L&M Healthcare Communications (Medical Communications), and Engage (European footprint). Partnering with 95% of top 20 global pharmaceutical companies, Fingerpaint is human-led and AI-enabled, combining ML, LLMs, and agentic frameworks to power data-driven commercialization.

Product and service10 records
1Fingerpaint Marketing
CategoryPharmaceutical marketing services
Description

Core marketing solution offering award-winning creative, strategic and scientific partnerships, omnichannel activation, data-driven CRM, and HCP and patient engagement across therapeutic areas including rare disease, neurology, and immunology. Designed for global pharmaceutical and life sciences brand teams.

2Fingerpaint Multicultural
CategoryMulticultural pharmaceutical marketing
Description

Award-winning multicultural marketing agency using the proprietary Pharmacultural methodology, combining cross-cultural analytics with pharma expertise to deliver ROI-driven campaigns for African American, US Hispanic and other multicultural audiences. For pharma brand teams targeting multicultural patient populations.

3Fingerpaint Media and Activation
CategoryHealthcare media planning and activation
Description

Media planning, activation, and optimization services for pharma brands, featuring omnichannel strategy, programmatic buying, customer journey orchestration, and real-time engagement analytics. Targeted at brand and media leads at pharmaceutical manufacturers.

4Fingerpaint Branding
CategoryPharmaceutical branding and naming
Description

Global pharmaceutical and life sciences branding consultancy offering proprietary naming, nonproprietary naming, clinical trial branding, MedTech branding, corporate branding, visual identity, brand strategy, and regulatory guidance. Powered by the proprietary Prima AI toolkit. Trusted by 48% of the top 100 pharma companies.

5Fingerpaint Market Access
CategoryPharmaceutical market access services
Description

Market access and patient support services spanning strategic planning, launch optimization, patient and provider support programs, 340B program management, contract compliance, revenue leakage solutions, and value proposition development. For pharmaceutical market access and patient services teams.

6Fingerpaint Medical Communications
CategoryMedical communications
Description

Medical communications services including strategy and innovation, medical and disease state education, omnichannel media engagement, HCP and patient promotional communications, and live/virtual educational events such as advisory boards, speaker bureaus, and congress support, delivered via the proprietary STARS event portal.

7Fingerpaint Medical Affairs
CategoryMedical affairs services
Description

Medical affairs agency offering communication strategy, publications, medical education, medical information services, opinion leader engagement, and digital execution. For medical affairs teams at pharmaceutical and biotech companies.

8Fingerpaint Europe
CategoryEuropean healthcare marketing services
Description

Dedicated European agency providing globally-minded marketing with local market customization, covering marketing, media and activation, medical communications, medical affairs, naming and branding, and multicultural services across European markets for biopharma clients.

9Prima AI-powered Branding Toolkit
CategoryProprietary technology — AI branding
Description

Proprietary AI-powered branding toolkit combining algorithmic precision with creative strategy for pharmaceutical naming, visual brand systems, global linguistics evaluations, name resonance testing, and POCA / medication error risk assessments. Sold as part of Fingerpaint Branding services to pharmaceutical and life sciences brand teams.

10STARS Event Portal
CategoryProprietary technology — event management
Description

Event Management, Tracking and Reporting Portal providing end-to-end management of live and virtual educational events including advisory boards, speaker training, and congress support for medical communications clients.

Scale indicator16 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-11-11
Description

Acquisition of L&M Healthcare Communications, a full-service New Jersey-based medical communications agency serving biotech and pharmaceutical companies. Brings over two decades of experience with peer-to-peer educational programs and speaker bureau services. Now part of Fingerpaint Medical's Medical Communications portfolio, expanding capabilities for comprehensive and impactful offerings.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

Acquisition of Blackpoint strengthening Market Access segment with expanded expertise in 340B program management, contract compliance, and revenue leakage solutions. Fully integrated into organization with specialized talent generating measurable value for clients.

3Engage (London-based healthcare marketing firm)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-12-14
Description

Acquisition of Engage, a London-based healthcare marketing firm, to enhance data, analytics, and global presence. Deal aimed to strengthen Fingerpaint's European footprint and global omnichannel solutions for biopharma clients, establishing Fingerpaint Europe.

newswire.ca
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Eversana is an independent life sciences commercial services firm offering market access, patient services, and integrated commercialization support. It is comparable to Fingerpaint's Market Access segment and broader commercialization platform on go-to-market and patient access engagements.

TypeDirect peer
Description

ConcentricLife is an independent healthcare creative and communications agency with strong medical communications capabilities serving global pharma clients. It competes with Fingerpaint on creative excellence and integrated pharma brand work, particularly across European and US markets.

TypeDirect peer
Description

AbelsonTaylor is a long-standing independent healthcare advertising agency specializing in DTC and HCP pharmaceutical marketing, with strong creative and branding capabilities. It is comparable to Fingerpaint Marketing on integrated pharma creative and brand-building engagements.

TypeDirect peer
Description

Omnicom Health Group is the dedicated healthcare marketing and communications network within Omnicom Group, providing creative, medical, and market access services to global pharma. It competes head-to-head with Fingerpaint on integrated pharma commercialization engagements and global account scope.

TypeDirect peer
Description

IPG Health is Interpublic Group's healthcare marketing and communications network, including McCann Health and FCB Health, serving most top 20 pharma companies globally. It is a primary direct competitor to Fingerpaint across creative, medical, and branding services.

TypeDirect peer
Description

Havas Health & You is the healthcare and wellness network within Havas, providing integrated marketing, communications, and consulting services to life sciences companies. It competes with Fingerpaint on global pharma client engagements and integrated platform positioning.

TypeDirect peer
Description

CMI Media Group is an independent healthcare media and communications agency focused exclusively on life sciences, providing media planning, activation, and omnichannel strategy. It is comparable to Fingerpaint's Media & Activation and integrated marketing offerings, particularly on HCP engagement.

TypeDirect peer
Description

Real Chemistry is an independent healthcare marketing, communications, and data-driven agency serving top 20 pharma clients across marketing, medical affairs, and patient engagement. It is one of the closest independent-platform comparables to Fingerpaint in scale and integrated offering.

TypeDirect peer
Description

Publicis Health is the healthcare-focused arm of Publicis Groupe and one of the largest global healthcare communications networks, offering marketing, medical communications, and market access services. It is the most direct large-network competitor to Fingerpaint's integrated commercialization platform for top 20 pharma clients.

TypeBroad incumbent
Description

WPP operates major healthcare marketing networks including VMLY&R Health and Ogilvy Health, providing integrated communications to global pharma. It is a broad incumbent competitor at the holding-company level, with significantly greater global scale than Fingerpaint across media, creative, and communications.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat7 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability13 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles22 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A8 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Fingerpaint

Healthcare Marketing and Commercialization Servicesfingerpaint.com

Fingerpaint Group is a PE-backed, integrated life sciences commercialization platform serving 95% of the top 20 global pharma companies through eight AI-enabled sub-brands spanning marketing, medical communications, market access, and branding.

What Fingerpaint does

Fingerpaint Group is a privately held, PE-backed (Knox Lane) integrated commercialization platform for life sciences, founded in 2008 and headquartered in Cedar Knolls, NJ with offices in Saratoga Springs, NY and London. The company serves global pharmaceutical, biotechnology, medical device, and animal health companies through eight specialized sub-brands: Marketing, Medical Communications, Medical Affairs, Market Access, Branding, Media & Activation, Multicultural, and Europe. Underlying these services is an AI-enabled technology stack including the proprietary Prima™ branding toolkit, LLM-powered unification of siloed life sciences data, predictive EPI-based patient modeling, and agentic frameworks integrated into operational workflows, governed by a newly appointed Chief Technology & Product Officer.

The company generates revenue through B2B professional services engagements, including project-based work, retainers, and integrated multi-solution contracts sold via direct enterprise sales to senior pharma decision-makers. Nearly 200 active clients span the top 20 global pharmaceutical companies (95% partnership rate) and 22 of the top 25, with over 60% of revenue from the top 50 pharma accounts and roughly half concentrated in oncology, immunology, and neurology. Two-thirds of partners engage multiple solutions across the platform, driving cross-sell economics and stickiness.

Growth has been propelled by an aggressive acquisition cadence (eight acquisitions since 2021 including Engage, Leaderboard, Emcay, Parsons Medical, PharmaHEALTHLabs, MYND, Blackpoint, and L&M Healthcare Communications), a 2025 record-revenue year with 21% growth, and a 2026 leadership transition that elevated internal successors to the CEO, Group President, and President of Marketing Services roles. The company has earned MM+M top-100 recognition for 15 consecutive years and became the first independent agency to win Network of the Year at the 2026 Manny Awards, validating the integrated platform thesis.

Fingerpaint firmographics

Firmographics
Name
Fingerpaint
Legal name
Fingerpaint Marketing, Inc.
Website
https://fingerpaint.com
Company type
Private
Founded year
2008
Operating status
Operating
Headcount range
101–250 employees
Short description
Fingerpaint Group is a PE-backed, integrated life sciences commercialization platform serving 95% of the top 20 global pharma companies through eight AI-enabled sub-brands spanning marketing, medical communications, market access, and branding.
Ownership category
akta.pro rank

Fingerpaint industry classification

Industry
Product category
Healthcare Marketing and Commercialization Services
akta.pro primary industry
Hand Hygiene & Skin Antisepsis (Soaps, Sanitizers, Surgical Scrubs, CHG Prep) (HLAHANAE)

Keywords

  • Healthcare marketing services
  • Pharmaceutical commercialization
  • Medical communications agency
  • Market access solutions
  • Pharmaceutical branding

Where Fingerpaint is headquartered

Location

Headquarters

HQ city
Saratoga Springs
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Fingerpaint business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Healthcare Marketing and Communications Services: Full-service healthcare agency providing integrated commercialization services for life sciences companies. Revenue generated through project-based engagements, retainer agreements, and comprehensive marketing solutions spanning creative, strategy, media, and medical communications.
  2. Integrated Platform Solutions: Multi-solution platform generating cross-sell revenue. Two-thirds of partners engage multiple solutions across Marketing, Medical, Branding, and Market Access segments. Revenue mix includes high-growth therapeutic areas (oncology, immunology, neurology) representing half of all revenue.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Fingerpaint product offering

Product offering

Core offering

Fingerpaint Group is an integrated healthcare commercialization agency that delivers marketing, medical communications, medical affairs, market access, branding, multicultural, media and activation, and European services to life sciences companies. It sells these to pharmaceutical, biotechnology, medical device, and animal health clients through eight specialized solution lines plus the proprietary Prima AI-powered branding toolkit, funded by project-based engagements and retainer agreements.

Product overview

Fingerpaint Group is a unified commercialization platform for life sciences, combining imagination with innovation to unlock brand greatness. The platform integrates multiple specialized solutions: Fingerpaint Marketing (core marketing and creative), Fingerpaint Multicultural (pharmacultural marketing), Fingerpaint Media and Activation (omnichannel media strategy), Fingerpaint Branding (pharmaceutical naming with proprietary Prima AI toolkit), Fingerpaint Market Access (patient support and 340B management), Fingerpaint Medical Communications (peer-to-peer education and speaker bureaus), and Fingerpaint Medical Affairs (publications and KOL engagement). Fingerpaint Europe extends capabilities across the continent. Supporting services include Mynd affiliate. The company has completed strategic acquisitions of Blackpoint (Market Access), L&M Healthcare Communications (Medical Communications), and Engage (European footprint). Partnering with 95% of top 20 global pharmaceutical companies, Fingerpaint is human-led and AI-enabled, combining ML, LLMs, and agentic frameworks to power data-driven commercialization.

Differentiator

Problem solved

Functional benefit

Brands

  • Fingerpaint Marketing: Core marketing services including creative, digital activation, strategy, media strategy, data analytics, and science solutions
  • Fingerpaint Medical Communications
  • Fingerpaint Medical Affairs
  • Fingerpaint Market Access
  • Fingerpaint Branding
  • Fingerpaint Media and Activation
  • Fingerpaint Multicultural
  • Fingerpaint Europe
  • Mynd
  • BlackPoint

Products and services

  • Fingerpaint Marketing Core marketing solution offering award-winning creative, strategic and scientific partnerships, omnichannel activation, data-driven CRM, and HCP and patient engagement across therapeutic areas including rare disease, neurology, and immunology. Designed for global pharmaceutical and life sciences brand teams.
  • Fingerpaint Multicultural Award-winning multicultural marketing agency using the proprietary Pharmacultural methodology, combining cross-cultural analytics with pharma expertise to deliver ROI-driven campaigns for African American, US Hispanic and other multicultural audiences. For pharma brand teams targeting multicultural patient populations.
  • Fingerpaint Media and Activation Media planning, activation, and optimization services for pharma brands, featuring omnichannel strategy, programmatic buying, customer journey orchestration, and real-time engagement analytics. Targeted at brand and media leads at pharmaceutical manufacturers.
  • Fingerpaint Branding Global pharmaceutical and life sciences branding consultancy offering proprietary naming, nonproprietary naming, clinical trial branding, MedTech branding, corporate branding, visual identity, brand strategy, and regulatory guidance. Powered by the proprietary Prima AI toolkit. Trusted by 48% of the top 100 pharma companies.
  • Fingerpaint Market Access Market access and patient support services spanning strategic planning, launch optimization, patient and provider support programs, 340B program management, contract compliance, revenue leakage solutions, and value proposition development. For pharmaceutical market access and patient services teams.
  • Fingerpaint Medical Communications Medical communications services including strategy and innovation, medical and disease state education, omnichannel media engagement, HCP and patient promotional communications, and live/virtual educational events such as advisory boards, speaker bureaus, and congress support, delivered via the proprietary STARS event portal.
  • Fingerpaint Medical Affairs Medical affairs agency offering communication strategy, publications, medical education, medical information services, opinion leader engagement, and digital execution. For medical affairs teams at pharmaceutical and biotech companies.
  • Fingerpaint Europe Dedicated European agency providing globally-minded marketing with local market customization, covering marketing, media and activation, medical communications, medical affairs, naming and branding, and multicultural services across European markets for biopharma clients.
  • Prima AI-powered Branding Toolkit Proprietary AI-powered branding toolkit combining algorithmic precision with creative strategy for pharmaceutical naming, visual brand systems, global linguistics evaluations, name resonance testing, and POCA / medication error risk assessments. Sold as part of Fingerpaint Branding services to pharmaceutical and life sciences brand teams.
  • STARS Event Portal Event Management, Tracking and Reporting Portal providing end-to-end management of live and virtual educational events including advisory boards, speaker training, and congress support for medical communications clients.

Quantifiable outcome

  • 21% revenue growth in 2025 with record revenue
  • +3 more outcomes

Companies that use Fingerpaint

Customer profile

Named customers5 records

Segments5 records

Ideal customer profiles3 records

Fingerpaint technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability13 records

Feature3 records

Fingerpaint partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • L&M Healthcare CommunicationscoreStrategic or Co-development Partner · 11 November 2025Acquisition of L&M Healthcare Communications, a full-service New Jersey-based medical communications agency serving biotech and pharmaceutical companies. Brings over two decades of experience with peer-to-peer educational programs and speaker bureau services. Now part of Fingerpaint Medical's Medical Communications portfolio, expanding capabilities for comprehensive and impactful offerings.
  • BlackpointcoreStrategic or Co-development Partner · 1 January 2025Acquisition of Blackpoint strengthening Market Access segment with expanded expertise in 340B program management, contract compliance, and revenue leakage solutions. Fully integrated into organization with specialized talent generating measurable value for clients.
  • Engage (London-based healthcare marketing firm)coreStrategic or Co-development Partner · 14 December 2021Acquisition of Engage, a London-based healthcare marketing firm, to enhance data, analytics, and global presence. Deal aimed to strengthen Fingerpaint's European footprint and global omnichannel solutions for biopharma clients, establishing Fingerpaint Europe.

Scale indicators16 records

Recent moves6 records

Expansion highlights6 records

Fingerpaint competitors and assessment

Company assessment

Direct peers

  • Eversana: Eversana is an independent life sciences commercial services firm offering market access, patient services, and integrated commercialization support. It is comparable to Fingerpaint's Market Access segment and broader commercialization platform on go-to-market and patient access engagements.
  • ConcentricLife: ConcentricLife is an independent healthcare creative and communications agency with strong medical communications capabilities serving global pharma clients. It competes with Fingerpaint on creative excellence and integrated pharma brand work, particularly across European and US markets.
  • AbelsonTaylor: AbelsonTaylor is a long-standing independent healthcare advertising agency specializing in DTC and HCP pharmaceutical marketing, with strong creative and branding capabilities. It is comparable to Fingerpaint Marketing on integrated pharma creative and brand-building engagements.
  • Omnicom Health Group: Omnicom Health Group is the dedicated healthcare marketing and communications network within Omnicom Group, providing creative, medical, and market access services to global pharma. It competes head-to-head with Fingerpaint on integrated pharma commercialization engagements and global account scope.
  • IPG Health: IPG Health is Interpublic Group's healthcare marketing and communications network, including McCann Health and FCB Health, serving most top 20 pharma companies globally. It is a primary direct competitor to Fingerpaint across creative, medical, and branding services.
  • Havas Health & You: Havas Health & You is the healthcare and wellness network within Havas, providing integrated marketing, communications, and consulting services to life sciences companies. It competes with Fingerpaint on global pharma client engagements and integrated platform positioning.
  • CMI Media Group: CMI Media Group is an independent healthcare media and communications agency focused exclusively on life sciences, providing media planning, activation, and omnichannel strategy. It is comparable to Fingerpaint's Media & Activation and integrated marketing offerings, particularly on HCP engagement.
  • Real Chemistry: Real Chemistry is an independent healthcare marketing, communications, and data-driven agency serving top 20 pharma clients across marketing, medical affairs, and patient engagement. It is one of the closest independent-platform comparables to Fingerpaint in scale and integrated offering.
  • Publicis Health: Publicis Health is the healthcare-focused arm of Publicis Groupe and one of the largest global healthcare communications networks, offering marketing, medical communications, and market access services. It is the most direct large-network competitor to Fingerpaint's integrated commercialization platform for top 20 pharma clients.

Broad incumbents

  • WPP (VMLY&R Health / Ogilvy Health): WPP operates major healthcare marketing networks including VMLY&R Health and Ogilvy Health, providing integrated communications to global pharma. It is a broad incumbent competitor at the holding-company level, with significantly greater global scale than Fingerpaint across media, creative, and communications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat7 records

Key risks6 records

Key highlights7 records

Customer concentration

Fingerpaint social profiles

Digital presence

Fingerpaint compliance and trust

Trust signal

Compliance3 records

Fingerpaint financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Fingerpaint leadership team

Management profile

Number of profiles

Profiles22 records

Fingerpaint subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Fingerpaint funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Fingerpaint M&A and investment

M&A and investment

M&A8 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Fingerpaint

What does Fingerpaint do?

Fingerpaint Group is an integrated healthcare commercialization agency that delivers marketing, medical communications, medical affairs, market access, branding, multicultural, media and activation, and European services to life sciences companies. It sells these to pharmaceutical, biotechnology, medical device, and animal health clients through eight specialized solution lines plus the proprietary Prima AI-powered branding toolkit, funded by project-based engagements and retainer agreements.

Is Fingerpaint a public or private company?

Fingerpaint is a private company. It is classified as private equity controlled and is currently operating.

When was Fingerpaint founded?

Fingerpaint was founded in 2008. It employs 101 to 250 people.

Where is Fingerpaint based?

Fingerpaint is headquartered in Saratoga Springs, United States, in the North America region.

How does Fingerpaint make money?

Two revenue lines are on record. Healthcare Marketing and Communications Services are the primary driver. The others are integrated Platform Solutions.

Who are Fingerpaint's main competitors?

Direct peers on record are Eversana, ConcentricLife, AbelsonTaylor, Omnicom Health Group, IPG Health, Havas Health & You, CMI Media Group, Real Chemistry and Publicis Health. WPP (VMLY&R Health / Ogilvy Health) is listed as a broad incumbent.

Does Fingerpaint have an API?

No public API is recorded for Fingerpaint.

What industry is Fingerpaint in?

Fingerpaint's product category is Healthcare Marketing and Commercialization Services. Its primary akta.pro industry code is HLAHANAE, Hand Hygiene & Skin Antisepsis (Soaps, Sanitizers, Surgical Scrubs, CHG Prep).

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireFingerpaint Group Appoints Wyatt Gotbetter as President of Market AccessFingerpaint Group appointed Wyatt Gotbetter as president of market access, leading its integrated suite of capabilities. Gotbetter brings nearly 30 years of experience, including roles at Cytel and Parexel. The hire deepens Fingerpaint's market access capabilities for clients across development and commercialization.American City Business JournalsLargest Advertising Agencies in Raleigh, DurhamThe 25 largest advertising agencies in the Triangle employ over 800 professionals, with Sokal Media Group ranked first. TriMark Digital and McKinney follow with 80 and 75 staff respectively. The list also includes Fingerpaint Medical with 45 professionals.Third NewsLatifa Alladina Joins Fingerpaint Marketing as General Manager to Drive Growth and InnovationOn June 16, 2026, Fingerpaint Group announced the appointment of Latifa Alladina as General Manager of Fingerpaint Marketing, bringing over 25 years of healthcare industry experience from agencies including Area 23, Digitas Health, and AgencyRx. Alladina's hire is positioned as a strategic move to strengthen leadership and support the company's ambitious growth plans, following record revenues and 21% growth last year. The appointment underscores Fingerpaint's focus on talent acquisition as it pursues its 15th consecutive year on MM+M's top 100 agencies list.PR NewswireFingerpaint Group Appoints Latifa Alladina as General Manager of Fingerpaint MarketingFingerpaint Group announced the appointment of Latifa Alladina as general manager of Fingerpaint Marketing, effective immediately. Alladina brings more than 25 years of healthcare industry experience, including roles at Area 23, Digitas Health, and Remedy Edge, and holds a PharmD from Duquesne University. The agency, which closed 2025 with record revenue and 21% growth, noted this as its 15th consecutive year on MM+M's top 100 agencies list.PR NewswireFingerpaint Group Announces Verified Climate TargetsFingerpaint Group announced that the Science Based Targets initiative (SBTi) has validated its near-term emissions reduction targets, including a commitment to reduce absolute scope 1 and 2 GHG emissions by 55.9% by 2033 and scope 3 GHG emissions by 61.1% per USD value added. The company has already achieved an 8% reduction in total emissions from 2,042 metric tons CO₂e in 2023 to 1,872 in 2024, primarily through office downsizing and reduced business travel. Fingerpaint is positioning the validated targets as a differentiator for serving pharmaceutical and life sciences clients that face increasing supply chain ESG scrutiny.PR NewswireFingerpaint Group Unifies Operations and Strategy to Accelerate Integrated GrowthFingerpaint Group, a healthcare agency and unified commercialization platform for life sciences, announced two enterprise-wide leadership appointments on May 5, 2026, naming Stephanie Spicer as Group Managing Director, Operations, and Nick Megjugorac as Chief Strategy Officer, both reporting to Group President Mark Willmann. The company reported record revenue for 2025 and partners with 95% of the top 20 global pharmaceutical companies, with two-thirds of those partners engaging multiple solutions across the platform. The appointments are designed to embed AI into operational processes and unify strategic direction across marketing, medical, branding, and market access solutions to support the company's scale strategy.PR NewswireA Masterpiece of Integration: Fingerpaint Group Wins Network of the Year at 2026 Manny AwardsFingerpaint Group won Network of the Year and Best Consumer Digital Campaign at the 2026 Manny Awards, becoming the first independent agency to secure the Network of the Year title. The wins across multiple categories validate the company's integrated commercialization platform model connecting marketing, medical communications, and market access for life sciences companies. The company reports partnerships with 95% of the top 20 global pharmaceutical companies, with two-thirds of partners engaging multiple solutions across the platform.PR NewswireFingerpaint Group's Integrated Strength Earns Six 2026 Manny Nominations, Including Network of the YearMed Ad News named Fingerpaint Group a finalist in six categories for the 2026 Manny Awards, including Network of the Year, recognizing the company's integrated platform that combines marketing, medical communications, and market access for life sciences companies. The nominations span the company's core subsidiaries: Fingerpaint Medical, Fingerpaint Market Access, and Fingerpaint Marketing, which together serve six of the top ten pharmaceutical brands worldwide. The Manny Awards ceremony will be held on April 23, 2026, in New York City.MorningstarFingerpaint Group's Integrated Strength Earns Six 2026 Manny Nominations, Including Network of the YearMed Ad News named Fingerpaint Group a finalist in six categories for the 2026 Manny Awards, including Network of the Year, recognizing the agency's integrated platform approach across marketing, medical communications, and market access. The nominations span multiple agency divisions—Fingerpaint Medical, Fingerpaint Market Access, and Fingerpaint Marketing—each recognized in distinct categories such as MedComms Agency of the Year, Market Access Agency of the Year, and Best Consumer and Professional Digital Campaigns. The 36th annual Manny Awards ceremony is scheduled for April 23, 2026, in New York City.PR NewswireFingerpaint Group Announces Historic Leadership Promotions, Elevating Homegrown Talent to Lead the Company's Next ChapterFingerpaint Group announced a landmark leadership transition, promoting Bill McEllen from Global President to Chief Executive Officer, succeeding founder Ed Mitzen, while also elevating Mark Willmann to Group President and Tracy Blackwell to President of Marketing Services. The promotions follow the company's most successful year, with record revenue in 2025 driven by strength across all three operating segments, serving nearly 200 active clients including partnerships with 22 of the top 25 pharmaceutical companies. Ed Mitzen, who founded the healthcare marketing agency in 2008, will remain as an active board member.